Headlands Technologies LLC Travere Therapeutics, Inc. Transaction History
Headlands Technologies LLC
- $939 Million
- Q4 2024
A detailed history of Headlands Technologies LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 4,048 shares of TVTX stock, worth $94,439. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,048
Previous 13,685
70.42%
Holding current value
$94,439
Previous $191,000
63.35%
% of portfolio
0.01%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding TVTX
# of Institutions
213Shares Held
94.1MCall Options Held
1.2MPut Options Held
778K-
Black Rock Inc. New York, NY7.64MShares$178 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.36MShares$172 Million1.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.74MShares$157 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.97MShares$116 Million3.46% of portfolio
-
Macquarie Group LTD Australia, C34.26MShares$99.4 Million0.09% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.5B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...